Inflammatory Breast Cancer International Consortium | IBC-IC HomepageInflammatory Breast Cancer International Consortium | IBC-IC

Luc Yves Dirix, MD

Luc Yves Dirix, MD

Clinician + Researcher

Title(s)

  • Head of Department of Medical Oncology, GzA Hospitals, Antwerp, Belgium
  • Director of The Translational Cancer Research Unit, GzA Hospitals, Antwerp, Belgium

Location(s)

  • Sint-Augustinus Cancer Center
  • 24 Oosterveldlaan
  • 2610 Wilrijk-Antwerp
  • Belgium
  • Phone: 00323-4433737
  • Fax: 00323-4433009

Affiliations and Memberships

Recent Publications

Differential impact of RB status on E2F1 reprogramming in human cancer
Journal of Clinical Investigation; January 2, 2018

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients
Molecular Oncology; January 1, 2018

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Breast Cancer Research and Treatment; 2017

Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial
Lancet Oncology; September 18, 2017

Join IBC-IC

Become part of our international consortium of researchers, clinicians, advocates and centers worldwide dedicated to ending IBC.

IBCIC.org makes every effort to keep researcher information as up-to-date as possible.
Contact this researcher to confirm any information regarding his or her profile.